ClinicalTrials.govpublic full text
Master Protocol to Assess the Safety and Antitumor Activity of Genetically Engineered T Cells in NY-ESO-1 and/or LAGE-1a Positive Solid Tumors
neoplasms, adoptive t-cell therapy, advanced metastatic disease, advanced unresectable disease, synovial sarcoma, myxoid/round cell liposarcoma, gsk3377794, positive solid tumors, t-cell receptors, leukapheresis, letetresgene autoleucel, lete-cel
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 979170
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.